Mr. Scott is a fundamental senior research analyst at Causeway. He joined the firm in August 2022. His current responsibilities include coverage of companies in the pharmaceuticals and biotechnology sectors.
Prior to joining Causeway, Mr. Scott was vice president of Equity Research Large Cap Biotech at J.P. Morgan. From 2017 to 2019, he was an associate at Goldman Sachs covering large cap biopharma. Prior to that, Mr. Scott was an associate at Jefferies LLC, covering Global Large Cap Pharma.
Mr. Scott earned a BS in molecular, cell, and developmental biology from the University of California, Santa Cruz.